Akèy › Ekzema
Etid klinik pou Ekzema ap rekrite nan Etazini
28 etid pou Ekzema ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- San Antonio, TX7 etid
- Birmingham, AL6 etid
- New York City, NY5 etid
- Los Angeles, CA5 etid
- Indianapolis, IN5 etid
- San Diego, CA5 etid
- Phoenix, AZ4 etid
- Huntington Beach, CA4 etid
- Santa Clarita, CA4 etid
- Miami, FL4 etid
- Washington, DC4 etid
- Pittsburgh, PA4 etid
- St. Petersburg, FL3 etid
- Cleveland, OH3 etid
- Louisville, KY3 etid
- Tampa, FL3 etid
- Sacramento, CA3 etid
- Santa Monica, CA3 etid
- Meridian, ID3 etid
- Little Rock, AR3 etid
- San Francisco, CA3 etid
Pa eta
- Alabama6 etid
- Arizona4 etid
- Arkansas4 etid
- Florid9 etid
- Idaho3 etid
- Illinois3 etid
- Indiana5 etid
- Kalifòni16 etid
- Maryland6 etid
- Michigan3 etid
- Missouri4 etid
- New York7 etid
- North Carolina3 etid
- Ohio5 etid
- Pennsylvania5 etid
- South Carolina5 etid
- Texas11 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993Effects of Treatments on Atopic Dermatitis
Ap rekriteFaz 2Volontè an sante akeyi
Laj 2 a 50 · Tout sèks · Mizajou Sep 28, 2026 · NCT01631617A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Ap rekriteFaz 3
Laj 6 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807268A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07216027A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807281First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07527923Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 100 · Tout sèks · Mizajou Sep 16, 2026 · NCT00605878Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Ap rekriteEtid obsèvasyon
Laj 12 a 89 · Tout sèks · Mizajou Sep 15, 2026 · NCT07645820The Impact of Dietary Salt on the Severity of Eczema
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07487831Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Ap rekrite
Laj 13 a 17 · Tout sèks · Mizajou Sep 8, 2026 · NCT07746427A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Sep 4, 2026 · NCT07355075A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599813Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Ap rekriteFaz 4
Laj 12 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07560618Cardamom and Topical Roseomonas in Atopic Dermatitis
Ap rekriteFaz 2
Laj 2 a 100 · Tout sèks · Mizajou Aug 13, 2026 · NCT06096857A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 a 74 · Tout sèks · Mizajou Aug 12, 2026 · NCT07037901Sodium in the Skin and Atopic Dermatitis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06998446Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Ap rekriteFaz 1
Laj 6 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT05995964The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT06928246Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT07441395Flourish: Exploring the Early Infant Gut Microbiome
Ap rekriteVolontè an sante akeyi
0 Months – 3 Months · Tout sèks · Mizajou Feb 24, 2026 · NCT07333482Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 30, 2025 · NCT00177268Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.